Advertisement

Index by author

December 01, 1990; Volume 38,Issue 6

A

  1. Audhya, T

    1. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
      R J Lukas, T Audhya, G Goldstein and L Lucero
      Molecular Pharmacology December 1990, 38 (6) 887-894;

B

  1. Bendele, A M

    1. Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats.
      T D Lindstrom, B R Hanssen and A M Bendele
      Molecular Pharmacology December 1990, 38 (6) 829-835;

  2. Bleakman, D

    1. Bradykinin-induced modulation of calcium signals in rat dorsal root ganglion neurons in vitro.
      D Bleakman, S A Thayer, S R Glaum and R J Miller
      Molecular Pharmacology December 1990, 38 (6) 785-796;

  3. Bonner, T I

    1. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
      J Wess, T I Bonner and M R Brann
      Molecular Pharmacology December 1990, 38 (6) 872-877;

  4. Boulay, G

    1. Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
      G Guillemette, I Favreau, G Boulay and M Potier
      Molecular Pharmacology December 1990, 38 (6) 841-847;

  5. Boutjdir, M

    1. High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
      M Boutjdir, P F Méry, R Hanf, A Shrier and R Fischmeister
      Molecular Pharmacology December 1990, 38 (6) 758-765;

  6. Brann, M R

    1. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
      J Wess, T I Bonner and M R Brann
      Molecular Pharmacology December 1990, 38 (6) 872-877;

  7. Breittmayer, J P

    1. Mechanism of the cardiotoxic action of palytoxin.
      C Frelin, P Vigne and J P Breittmayer
      Molecular Pharmacology December 1990, 38 (6) 904-909;

  8. Bronner, C

    1. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
      J L Bueb, M Mousli, C Bronner, B Rouot and Y Landry
      Molecular Pharmacology December 1990, 38 (6) 816-822;

  9. Browning, M D

    1. Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
      N J Leidenheimer, M D Browning, T V Dunwiddie, L D Hahner and R A Harris
      Molecular Pharmacology December 1990, 38 (6) 823-828;

  10. Bruns, R F

    1. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
      R F Bruns and J H Fergus
      Molecular Pharmacology December 1990, 38 (6) 939-949;
    2. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

  11. Buckley, N J

    1. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
      S Lazareno, N J Buckley and F F Roberts
      Molecular Pharmacology December 1990, 38 (6) 805-815;

  12. Budzik, G P

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  13. Bueb, J L

    1. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
      J L Bueb, M Mousli, C Bronner, B Rouot and Y Landry
      Molecular Pharmacology December 1990, 38 (6) 816-822;

  14. Bushfield, M

    1. Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
      M Bushfield, I Shoshani and R A Johnson
      Molecular Pharmacology December 1990, 38 (6) 848-853;

C

  1. Chu, C K

    1. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
      Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 929-938;

  2. Colby, C B

    1. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
      Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 929-938;

  3. Compton, D R

    1. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
      P H Reggio, H H Seltzman, D R Compton, W R Prescott and B R Martin
      Molecular Pharmacology December 1990, 38 (6) 854-862;

  4. Coughenour, L L

    1. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

  5. Courtland, G G

    1. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

D

  1. Dawson, T L

    1. Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes.
      T L Dawson, R A Nicholas and R Dingledine
      Molecular Pharmacology December 1990, 38 (6) 779-784;

  2. DePalo, L R

    1. Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
      L P Reagan, X H Ye, R Mir, L R DePalo and S J Fluharty
      Molecular Pharmacology December 1990, 38 (6) 878-886;

  3. Dillon, T P

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  4. Dingledine, R

    1. Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes.
      T L Dawson, R A Nicholas and R Dingledine
      Molecular Pharmacology December 1990, 38 (6) 779-784;

  5. Dodd, J H

    1. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

  6. Dunwiddie, T V

    1. Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
      N J Leidenheimer, M D Browning, T V Dunwiddie, L D Hahner and R A Harris
      Molecular Pharmacology December 1990, 38 (6) 823-828;

E

  1. el-Fakahany, E E

    1. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
      J R Hu and E E el-Fakahany
      Molecular Pharmacology December 1990, 38 (6) 895-903;

F

  1. Favreau, I

    1. Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
      G Guillemette, I Favreau, G Boulay and M Potier
      Molecular Pharmacology December 1990, 38 (6) 841-847;

  2. Fergus, J H

    1. Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
      R F Bruns and J H Fergus
      Molecular Pharmacology December 1990, 38 (6) 939-949;
    2. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

  3. Fernandez-Larsson, R

    1. Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase.
      R Fernandez-Larsson and J L Patterson
      Molecular Pharmacology December 1990, 38 (6) 766-770;

  4. Fischmeister, R

    1. High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
      M Boutjdir, P F Méry, R Hanf, A Shrier and R Fischmeister
      Molecular Pharmacology December 1990, 38 (6) 758-765;

  5. Fluharty, S J

    1. Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
      L P Reagan, X H Ye, R Mir, L R DePalo and S J Fluharty
      Molecular Pharmacology December 1990, 38 (6) 878-886;

  6. Frelin, C

    1. Mechanism of the cardiotoxic action of palytoxin.
      C Frelin, P Vigne and J P Breittmayer
      Molecular Pharmacology December 1990, 38 (6) 904-909;

G

  1. Gaginella, T S

    1. Regulation of guinea pig ileal electrolyte transport by M3-muscarinic acetylcholine receptors in vitro.
      J F Kachur, B L Sturm, T S Gaginella and L Noronha-Blob
      Molecular Pharmacology December 1990, 38 (6) 836-840;

  2. Ganey, P E

    1. Ethanol potentiates oxygen uptake and toxicity due to menadione bisulfite in perfused rat liver.
      P E Ganey, Y Takei, F C Kauffman and R G Thurman
      Molecular Pharmacology December 1990, 38 (6) 959-964;

  3. Glaum, S R

    1. Bradykinin-induced modulation of calcium signals in rat dorsal root ganglion neurons in vitro.
      D Bleakman, S A Thayer, S R Glaum and R J Miller
      Molecular Pharmacology December 1990, 38 (6) 785-796;

  4. Goldstein, G

    1. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
      R J Lukas, T Audhya, G Goldstein and L Lucero
      Molecular Pharmacology December 1990, 38 (6) 887-894;

  5. Guillemette, G

    1. Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
      G Guillemette, I Favreau, G Boulay and M Potier
      Molecular Pharmacology December 1990, 38 (6) 841-847;

H

  1. Haaseth, R C

    1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
      H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
      Molecular Pharmacology December 1990, 38 (6) 924-928;

  2. Hahner, L D

    1. Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
      N J Leidenheimer, M D Browning, T V Dunwiddie, L D Hahner and R A Harris
      Molecular Pharmacology December 1990, 38 (6) 823-828;

  3. Hanf, R

    1. High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
      M Boutjdir, P F Méry, R Hanf, A Shrier and R Fischmeister
      Molecular Pharmacology December 1990, 38 (6) 758-765;

  4. Hanssen, B R

    1. Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats.
      T D Lindstrom, B R Hanssen and A M Bendele
      Molecular Pharmacology December 1990, 38 (6) 829-835;

  5. Harris, R A

    1. Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
      N J Leidenheimer, M D Browning, T V Dunwiddie, L D Hahner and R A Harris
      Molecular Pharmacology December 1990, 38 (6) 823-828;

  6. Heyl, D L

    1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
      H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
      Molecular Pharmacology December 1990, 38 (6) 924-928;

  7. Holleman, W H

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  8. Holst, M A

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  9. Hu, J R

    1. Selectivity of McN-A-343 in stimulating phosphoinositide hydrolysis mediated by M1 muscarinic receptors.
      J R Hu and E E el-Fakahany
      Molecular Pharmacology December 1990, 38 (6) 895-903;

J

  1. Johnson, R A

    1. Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
      M Bushfield, I Shoshani and R A Johnson
      Molecular Pharmacology December 1990, 38 (6) 848-853;

K

  1. Kachur, J F

    1. Regulation of guinea pig ileal electrolyte transport by M3-muscarinic acetylcholine receptors in vitro.
      J F Kachur, B L Sturm, T S Gaginella and L Noronha-Blob
      Molecular Pharmacology December 1990, 38 (6) 836-840;

  2. Kauffman, F C

    1. Ethanol potentiates oxygen uptake and toxicity due to menadione bisulfite in perfused rat liver.
      P E Ganey, Y Takei, F C Kauffman and R G Thurman
      Molecular Pharmacology December 1990, 38 (6) 959-964;

  3. Kiso, Y

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  4. Korbonits, D

    1. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
      F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
      Molecular Pharmacology December 1990, 38 (6) 910-916;

L

  1. Landry, Y

    1. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
      J L Bueb, M Mousli, C Bronner, B Rouot and Y Landry
      Molecular Pharmacology December 1990, 38 (6) 816-822;

  2. Lazareno, S

    1. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
      S Lazareno, N J Buckley and F F Roberts
      Molecular Pharmacology December 1990, 38 (6) 805-815;

  3. Leidenheimer, N J

    1. Phosphorylation-independent effects of second messenger system modulators on gamma-aminobutyric acidA receptor complex function.
      N J Leidenheimer, M D Browning, T V Dunwiddie, L D Hahner and R A Harris
      Molecular Pharmacology December 1990, 38 (6) 823-828;

  4. Li, L A

    1. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
      E L Ochoa, L A Li, A Plummer and M G McNamee
      Molecular Pharmacology December 1990, 38 (6) 863-871;

  5. Liliom, K

    1. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
      F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
      Molecular Pharmacology December 1990, 38 (6) 910-916;

  6. Lindstrom, T D

    1. Effects of hepatic ischemia-reperfusion injury on the hepatic mixed function oxidase system in rats.
      T D Lindstrom, B R Hanssen and A M Bendele
      Molecular Pharmacology December 1990, 38 (6) 829-835;

  7. Lucero, L

    1. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
      R J Lukas, T Audhya, G Goldstein and L Lucero
      Molecular Pharmacology December 1990, 38 (6) 887-894;

  8. Lukas, R J

    1. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
      R J Lukas, T Audhya, G Goldstein and L Lucero
      Molecular Pharmacology December 1990, 38 (6) 887-894;

M

  1. Madeddu, L

    1. Mode of action of alpha-latrotoxin: role of divalent cations in Ca2(+)-dependent and Ca2(+)-independent effects mediated by the toxin.
      L Rosenthal, D Zacchetti, L Madeddu and J Meldolesi
      Molecular Pharmacology December 1990, 38 (6) 917-923;

  2. Martin, B R

    1. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
      P H Reggio, H H Seltzman, D R Compton, W R Prescott and B R Martin
      Molecular Pharmacology December 1990, 38 (6) 854-862;

  3. McNamee, M G

    1. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
      E L Ochoa, L A Li, A Plummer and M G McNamee
      Molecular Pharmacology December 1990, 38 (6) 863-871;

  4. Medzihradsky, F

    1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
      H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
      Molecular Pharmacology December 1990, 38 (6) 924-928;

  5. Meldolesi, J

    1. Mode of action of alpha-latrotoxin: role of divalent cations in Ca2(+)-dependent and Ca2(+)-independent effects mediated by the toxin.
      L Rosenthal, D Zacchetti, L Madeddu and J Meldolesi
      Molecular Pharmacology December 1990, 38 (6) 917-923;

  6. Méry, P F

    1. High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
      M Boutjdir, P F Méry, R Hanf, A Shrier and R Fischmeister
      Molecular Pharmacology December 1990, 38 (6) 758-765;

  7. Miller, R J

    1. Bradykinin-induced modulation of calcium signals in rat dorsal root ganglion neurons in vitro.
      D Bleakman, S A Thayer, S R Glaum and R J Miller
      Molecular Pharmacology December 1990, 38 (6) 785-796;

  8. Mir, R

    1. Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
      L P Reagan, X H Ye, R Mir, L R DePalo and S J Fluharty
      Molecular Pharmacology December 1990, 38 (6) 878-886;

  9. Mosberg, H I

    1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
      H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
      Molecular Pharmacology December 1990, 38 (6) 924-928;

  10. Mousli, M

    1. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
      J L Bueb, M Mousli, C Bronner, B Rouot and Y Landry
      Molecular Pharmacology December 1990, 38 (6) 816-822;

N

  1. Nicholas, R A

    1. Homomeric GluR1 excitatory amino acid receptors expressed in Xenopus oocytes.
      T L Dawson, R A Nicholas and R Dingledine
      Molecular Pharmacology December 1990, 38 (6) 779-784;

  2. Noronha-Blob, L

    1. Regulation of guinea pig ileal electrolyte transport by M3-muscarinic acetylcholine receptors in vitro.
      J F Kachur, B L Sturm, T S Gaginella and L Noronha-Blob
      Molecular Pharmacology December 1990, 38 (6) 836-840;

  3. Novosad, E I

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

O

  1. Ochoa, E L

    1. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
      E L Ochoa, L A Li, A Plummer and M G McNamee
      Molecular Pharmacology December 1990, 38 (6) 863-871;

  2. Omnaas, J R

    1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
      H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
      Molecular Pharmacology December 1990, 38 (6) 924-928;

  3. Opgenorth, T J

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  4. Orosz, F

    1. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
      F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
      Molecular Pharmacology December 1990, 38 (6) 910-916;

  5. Ovádi, J

    1. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
      F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
      Molecular Pharmacology December 1990, 38 (6) 910-916;

P

  1. Patterson, J L

    1. Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase.
      R Fernandez-Larsson and J L Patterson
      Molecular Pharmacology December 1990, 38 (6) 766-770;

  2. Plummer, A

    1. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
      E L Ochoa, L A Li, A Plummer and M G McNamee
      Molecular Pharmacology December 1990, 38 (6) 863-871;

  3. Potier, M

    1. Solubilization and partial characterization of inositol 1,4,5-trisphosphate receptor of bovine adrenal cortex reveal similarities with the receptor of rat cerebellum.
      G Guillemette, I Favreau, G Boulay and M Potier
      Molecular Pharmacology December 1990, 38 (6) 841-847;

  4. Prescott, W R

    1. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
      P H Reggio, H H Seltzman, D R Compton, W R Prescott and B R Martin
      Molecular Pharmacology December 1990, 38 (6) 854-862;

  5. Pugsley, T A

    1. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

R

  1. Rabe, C S

    1. Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor.
      C S Rabe and B Tabakoff
      Molecular Pharmacology December 1990, 38 (6) 753-757;

  2. Reagan, L P

    1. Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
      L P Reagan, X H Ye, R Mir, L R DePalo and S J Fluharty
      Molecular Pharmacology December 1990, 38 (6) 878-886;

  3. Reggio, P H

    1. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
      P H Reggio, H H Seltzman, D R Compton, W R Prescott and B R Martin
      Molecular Pharmacology December 1990, 38 (6) 854-862;

  4. Roberts, F F

    1. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
      S Lazareno, N J Buckley and F F Roberts
      Molecular Pharmacology December 1990, 38 (6) 805-815;

  5. Rockway, T W

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  6. Rosenthal, L

    1. Mode of action of alpha-latrotoxin: role of divalent cations in Ca2(+)-dependent and Ca2(+)-independent effects mediated by the toxin.
      L Rosenthal, D Zacchetti, L Madeddu and J Meldolesi
      Molecular Pharmacology December 1990, 38 (6) 917-923;

  7. Rouot, B

    1. Activation of Gi-like proteins, a receptor-independent effect of kinins in mast cells.
      J L Bueb, M Mousli, C Bronner, B Rouot and Y Landry
      Molecular Pharmacology December 1990, 38 (6) 816-822;

S

  1. Schinazi, R F

    1. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
      Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 929-938;

  2. Seltzman, H H

    1. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
      P H Reggio, H H Seltzman, D R Compton, W R Prescott and B R Martin
      Molecular Pharmacology December 1990, 38 (6) 854-862;

  3. Shoshani, I

    1. Tissue levels, source, and regulation of 3'-AMP: an intracellular inhibitor of adenylyl cyclases.
      M Bushfield, I Shoshani and R A Johnson
      Molecular Pharmacology December 1990, 38 (6) 848-853;

  4. Shrier, A

    1. High affinity forskolin inhibition of L-type Ca2+ current in cardiac cells.
      M Boutjdir, P F Méry, R Hanf, A Shrier and R Fischmeister
      Molecular Pharmacology December 1990, 38 (6) 758-765;

  5. Smith, C B

    1. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
      H I Mosberg, D L Heyl, R C Haaseth, J R Omnaas, F Medzihradsky and C B Smith
      Molecular Pharmacology December 1990, 38 (6) 924-928;

  6. Solti, M

    1. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
      F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
      Molecular Pharmacology December 1990, 38 (6) 910-916;

  7. Sommadossi, J P

    1. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
      D A Weidner and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 797-804;
    2. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
      Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 929-938;

  8. Sturm, B L

    1. Regulation of guinea pig ileal electrolyte transport by M3-muscarinic acetylcholine receptors in vitro.
      J F Kachur, B L Sturm, T S Gaginella and L Noronha-Blob
      Molecular Pharmacology December 1990, 38 (6) 836-840;

T

  1. Tabakoff, B

    1. Glycine site-directed agonists reverse the actions of ethanol at the N-methyl-D-aspartate receptor.
      C S Rabe and B Tabakoff
      Molecular Pharmacology December 1990, 38 (6) 753-757;

  2. Takei, Y

    1. Ethanol potentiates oxygen uptake and toxicity due to menadione bisulfite in perfused rat liver.
      P E Ganey, Y Takei, F C Kauffman and R G Thurman
      Molecular Pharmacology December 1990, 38 (6) 959-964;

  3. Telegdi, M

    1. Dissimilar mechanisms of action of anticalmodulin drugs: quantitative analysis.
      F Orosz, M Telegdi, K Liliom, M Solti, D Korbonits and J Ovádi
      Molecular Pharmacology December 1990, 38 (6) 910-916;

  4. Thayer, S A

    1. Bradykinin-induced modulation of calcium signals in rat dorsal root ganglion neurons in vitro.
      D Bleakman, S A Thayer, S R Glaum and R J Miller
      Molecular Pharmacology December 1990, 38 (6) 785-796;

  5. Thomas, A M

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

  6. Thurman, R G

    1. Ethanol potentiates oxygen uptake and toxicity due to menadione bisulfite in perfused rat liver.
      P E Ganey, Y Takei, F C Kauffman and R G Thurman
      Molecular Pharmacology December 1990, 38 (6) 959-964;

  7. Tinney, F J

    1. Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.
      R F Bruns, J H Fergus, L L Coughenour, G G Courtland, T A Pugsley, J H Dodd and F J Tinney
      Molecular Pharmacology December 1990, 38 (6) 950-958;

V

  1. Vigne, P

    1. Mechanism of the cardiotoxic action of palytoxin.
      C Frelin, P Vigne and J P Breittmayer
      Molecular Pharmacology December 1990, 38 (6) 904-909;

  2. von Geldern, T W

    1. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
      T W von Geldern, G P Budzik, T P Dillon, W H Holleman, M A Holst, Y Kiso, E I Novosad, T J Opgenorth, T W Rockway and A M Thomas
      Molecular Pharmacology December 1990, 38 (6) 771-778;

W

  1. Weidner, D A

    1. 3'-Azido-3'-deoxythymidine inhibits globin gene transcription in butyric acid-induced K-562 human leukemia cells.
      D A Weidner and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 797-804;

  2. Wess, J

    1. Chimeric m2/m3 muscarinic receptors: role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis.
      J Wess, T I Bonner and M R Brann
      Molecular Pharmacology December 1990, 38 (6) 872-877;

  3. Williams, G J

    1. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
      Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 929-938;

Y

  1. Ye, X H

    1. Up-regulation of angiotensin II receptors by in vitro differentiation of murine N1E-115 neuroblastoma cells.
      L P Reagan, X H Ye, R Mir, L R DePalo and S J Fluharty
      Molecular Pharmacology December 1990, 38 (6) 878-886;

Z

  1. Zacchetti, D

    1. Mode of action of alpha-latrotoxin: role of divalent cations in Ca2(+)-dependent and Ca2(+)-independent effects mediated by the toxin.
      L Rosenthal, D Zacchetti, L Madeddu and J Meldolesi
      Molecular Pharmacology December 1990, 38 (6) 917-923;

  2. Zhu, Z

    1. Cellular metabolism of 3'-azido-2',3'-dideoxyuridine with formation of 5'-O-diphosphohexose derivatives by previously unrecognized metabolic pathways for 2'-deoxyuridine analogs.
      Z Zhu, R F Schinazi, C K Chu, G J Williams, C B Colby and J P Sommadossi
      Molecular Pharmacology December 1990, 38 (6) 929-938;
Back to top

In this issue

Advertisement